MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
0.5299
+0.0119
+2.30%
After Hours: 0.5299 0 0.00% 19:13 12/01 EST
OPEN
0.5300
PREV CLOSE
0.5180
HIGH
0.5300
LOW
0.5050
VOLUME
254.12K
TURNOVER
0
52 WEEK HIGH
9.81
52 WEEK LOW
0.4300
MARKET CAP
12.64M
P/E (TTM)
-0.0473
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TNXP last week (1120-1124)?
Weekly Report · 6d ago
Weekly Report: what happened at TNXP last week (1113-1117)?
Weekly Report · 11/20 11:36
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers cytosorbents (nasdaq:ctso) stock rose 17.3% to $1.29 during friday's pre-market session. Tonix pharmaceuticals stock rose 15.43% and butterfly network stock moved upwards by 12.6%. Renalytix stock increased by 11.66% and tracon pharma increased by 14.13%.
Benzinga · 11/17 13:06
Tonix Pharmaceut: Current report
Press release · 11/15 16:05
Tonix Pharmaceut: Current report
Press release · 11/13 12:13
Weekly Report: what happened at TNXP last week (1106-1110)?
Weekly Report · 11/13 11:29
Tonix Pharmaceuticals GAAP EPS of -$1.83, revenue of $4M
Tonix pharmaceuticals holding corp. Reports q3 gaap eps of -$1.83, revenue of $4m. Tonix pulls plug on drug tnx-601 er for depression, stock plunges 35%. Tonix slumps 33%, prices $4.5m equity.
Seeking Alpha · 11/10 16:45
Tonix Pharmaceut: Current report
Press release · 11/10 02:19
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg. Its portfolio consists of central nervous system (CNS), rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases and cancer. Its infectious disease portfolio includes a vaccine in development to prevent smallpox and mpox, vaccines to prevent COVID-19, a platform to make fully human monoclonal antibodies (mAbs), to treat COVID-19 and humanized anti-SARS-CoV-2 mAbs. Its product candidates include TNX-102 SL, TNX-4300, TNX-1900, TNX-601 ER and others.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.